Director's Dealing • Sep 18, 2019
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 6876M
Craneware plc
18 September 2019
Craneware plc
("Craneware" or the "Company")
Purchase of Shares by Directors
18 September 2019 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, announces the following purchases of ordinary shares of 1p each in the Company ('Ordinary Shares') in the Company:
| Director | Role | Number of Ordinary Shares purchased | Price per Ordinary Share | Date of purchase |
| George Elliott | Chairman | 1,500 | £22.00 | 17 September 2019 |
| Keith Neilson | CEO | 4,527 | £22.00 | 17 September 2019 |
| Ronald Verni | Senior Independent Director | 1,095 | £22.00 | 17 September 2019 |
| Russ Rudish | Independent Non-Executive Director | 1,095 | £22.00 | 17 September 2019 |
| Colleen Blye | Independent Non-Executive Director | 547 | £22.00 | 17 September 2019 |
Following these purchases of Ordinary Shares, the Directors of the Company hold the following number of Ordinary Shares in the Company:
| Director | Role | Number of Ordinary Shares held in the capital of the Company | Percentage of the Company's issued share capital held |
| George Elliott | Chairman | 11,500 | 0.04% |
| Keith Neilson | CEO | 3,387,174 | 12.69% |
| Craig Preston | CFO | 82,103 | 0.31% |
| Ronald Verni | Senior Independent Director | 1,095 | 0.004% |
| Russ Rudish | Independent Non-Executive Director | 1,095 | 0.004% |
| Colleen Blye | Independent Non-Executive Director | 547 | 0.002% |
Appendix:
PDMR notification: George Elliott
1. Details of the Restricted Person / person closely associated with him or her
a) Name George Elliott
2. Reason for the notification
a) Position / status Chairman
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction Purchase of Ordinary Shares
d) Price(s) and volume(s) Volume(s) 1,500, Price(s) £22.00
e) Aggregated information:
i. Aggregated volume Aggregate volume(s) 1,500
ii. Price Price(s) £22.00
f) Date of the transaction 2019-09-17
g) Place of the transaction London Stock Exchange (XLON)
PDMR notification: Keith Neilson
1. Details of the Restricted Person / person closely associated with him or her
a) Name Keith Neilson
2. Reason for the notification
a) Position / status CEO
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction Purchase of Ordinary Shares
d) Price(s) and volume(s) Volume(s) 4,527, Price(s) £22.00
e) Aggregated information:
i. Aggregated volume Aggregate volume(s) 4,527
ii. Price Price(s) £22.00
f) Date of the transaction 2019-09-17
g) Place of the transaction London Stock Exchange (XLON)
PDMR notification: Ronald Verni
3. Details of the Restricted Person / person closely associated with him or her
a) Name Ronald Verni
4. Reason for the notification
a) Position / status Non-Executive Director
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction Purchase of Ordinary Shares
d) Price(s) and volume(s) Volume(s) 1,095, Price(s) £22.00
e) Aggregated information:
i. Aggregated volume Aggregate volume(s) 1,095
ii. Price Price(s) £22.00
f) Date of the transaction 2019-09-17
g) Place of the transaction London Stock Exchange (XLON)
PDMR notification: Colleen Blye
1. Details of the Restricted Person / person closely associated with him or her
a) Name Colleen Blye
2. Reason for the notification
a) Position / status Non-Executive Director
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction Purchase of Ordinary Shares
d) Price(s) and volume(s) Volume(s) 547, Price(s) £22.00
e) Aggregated information:
i. Aggregated volume Aggregate volume(s) 547
ii. Price Price(s) £22.00
f) Date of the transaction 2019-09-17
g) Place of the transaction London Stock Exchange (XLON)
PDMR notification: Russ Rudish
1. Details of the Restricted Person / person closely associated with him or her
a) Name Russ Rudish
2. Reason for the notification
a) Position / status Non-Executive Director
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction Purchase of Ordinary Shares
d) Price(s) and volume(s) Volume(s) 1,095, Price(s) £22.00
e) Aggregated information:
i. Aggregated volume Aggregate volume(s) 1,095
ii. Price Price(s) £22.00
f) Date of the transaction 2019-09-17
g) Place of the transaction London Stock Exchange (XLON)
For further information, please contact:
| Craneware plc | Peel Hunt (NOMAD & Joint Broker) | Investec Bank (Joint Broker) | Alma (Financial PR) |
| +44 (0)131 550 3100 | +44 (0)20 7418 8900 | +44 (0)20 7597 5970 | +44 (0)203 405 0205 |
| Keith Neilson, CEO | Dan Webster | Patrick Robb | Caroline Forde |
| Craig Preston, CFO | George Sellar Guy Pengelley |
Sebastian Lawrence Henry Reast |
Hilary Buchanan Helena Bogle |
About Craneware
Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.
Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHEAENXFDPNEAF
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.